Leading biopharmaceutical track record

Our Track Record

We are the trusted Partner of most of the Top 20 global Pharma Companies and many innovative Biotech Companies.

Boehringer Ingelheim has a long history in the field of producing biologics. We have helped our customers bring 33 commercial biopharmaceuticals to the market, with three of these products ranking among the world's Top 20 best-selling biotech products. We take the responsibility of manufacturing consistently reliable biopharmaceutical products for patients very seriously, constantly investing in our people, our facilities and our innovation capabilities.

Our biomanufacturing plants have successfully undergone more than 130 regulatory cGMP (current good manufacturing practice) audits and pre-approval inspections (PAI) by global authorities. In addition, we regularly invite customers to inspect our facilities for themselves.

Our customers’ trust is our most important asset – so we take care of it.

International experiences with regulatory agencies e.g. FDA, EMA, Health Canada and PMDA
International experiences with regulatory agencies e.g. FDA, EMA, Health Canada and PMDA